Advertisement

The Global High Potency Active Pharmaceutical Ingredients Market to Grow 8.4% Annually Through 2015

16 Aug, 2010 @ 09:06 am EDT
  • Comments comments 0

ROCKVILLE, MD -- (Marketwire) -- 08/16/10 -- MarketResearch.com has announced the addition of GBI Research's new report "The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives Investment in Capacity" to their collection of Pharmaceuticals market reports. For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=2623014

Due to the growing targeted therapy approach in the treatment of diseases, the demand for high potency API is increasing fast. The major therapeutic application of these compounds is in oncology drugs. As oncology is the fastest growing therapeutic segment in the pharmaceutical industry, it is driving the high potency market worldwide.

Growth in oncology in the coming years, together with the increasing usage of high potency API in other therapies, is going to be major driver for the global market of high potency active pharmaceutical ingredients in the coming five years. The global high potency active pharmaceutical ingredients market is set to grow at a CAGR of 8.4% from 2009 to 2015.

This report provides an in-depth analysis of the global high potency active pharmaceutical ingredients industry. Included are detailed analysis and forecasts of the HPAPI markets in the major regions of the world. The report contains a global opportunity analysis, market trends, drivers and restraints, and a market share analysis of major producers in the important geographical markets of the world. It also includes market forecasts of the major countries.

Topics covered in the report include:

  • HPAPIs market revenues data from 2005 to 2009 and forecast for six years to 2015.
  • HPAPIs in key regions -- Europe, North America and Asia Pacific.
  • Coverage of the product types and therapeutic applications of the global HPAPIs market.
  • Drivers such as increasing demand due to the growth in better targeted drugs and restraints such as the economic recession for the global market as well as for the regional markets.
  • Information on the competitive landscape with the revenue shares of the leading companies in the major regions of the world such as Sigma Aldrich, Bristol Myers Squibb, Sanofi Aventis, Carbogen Amcis and Novasep.

For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=2623014

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Veronica Franco
MarketResearch.com
vfranco@marketresearch.com
240.747.3016

For more information, go to www.marketwire.com
Comments

Post Your Comment

*Name


advertisement
advertisement